Human BCAP31 (BAP31) knockout HEK-293T cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
BCAP31 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.
View Alternative Names
6C6 AG, 6C6-AG tumor-associated antigen, Accessory protein BAP 31, B-cell receptor-associated protein 31, BA31, BAP31_HUMAN, BCAP 31, BCR associated protein Bap 31, BCR-associated protein 31, CDM, CDM protein, DXS1357E, MS950, Protein CDM, RP23-329M9.5, p28 Bap31
- WB
Lab
Western blot - Human BCAP31 (BAP31) knockout HEK-293T cell lysate (AB257857)
Lane 1 : Wild-type HEK293T cell lysate (20 ug)
Lane 2 : BCAP31 knockout HEK293T cell lysate (20 ug)
Lane 3 : HeLa cell lysate (20 ug)
Lane 4 : NCCIT cell lysate (20 ug)
ab112993 was shown to specifically react with BAP31 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266634 (knockout cell lysate ab257857) was used. Wild-type and BAP31 knockout samples were subjected to SDS-PAGE. ab112993 and Anti-beta Tubulin [EP1331Y] - Microtubule Marker (ab52901) were incubated overnight at 4oC at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-BAP31 antibody [7A3BB6] (<a href='/en-us/products/primary-antibodies/bap31-antibody-7a3bb6-ab112993'>ab112993</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
BCAP31 knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human BCAP31 (BAP31) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-bcap31-bap31-knockout-hek-293t-cell-line-ab266634'>ab266634</a>)
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
NCCIT cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-680rd-preadsorbed-ab216777'>ab216777</a>) at 1/10000 dilution
Predicted band size: 28 kDa
Observed band size: 28 kDa
false
- WB
Lab
Western blot - Human BCAP31 (BAP31) knockout HEK-293T cell lysate (AB257857)
Lane 1 : Wild-type HEK293T cell lysate (20 ug)
Lane 2 : BCAP31 knockout HEK293T cell lysate (20 ug)
Lane 3 : HeLa cell lysate (20 ug)
Lane 4 : NCCIT cell lysate (20 ug)
ab109304 was shown to specifically react with BAP31 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266634 (knockout cell lysate ab257857) was used. Wild-type and BAP31 knockout samples were subjected to SDS-PAGE. ab109304 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4oC at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-BAP31 antibody [EPR3878(2)] (<a href='/en-us/products/primary-antibodies/bap31-antibody-epr38782-ab109304'>ab109304</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
BCAP31 knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human BCAP31 (BAP31) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-bcap31-bap31-knockout-hek-293t-cell-line-ab266634'>ab266634</a>)
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
NCCIT cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 28 kDa
Observed band size: 28 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human BCAP31 (BAP31) knockout HEK-293T cell lysate (AB257857)
Homozygous : Insertion of the selection cassette in exon 2
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Zygosity
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com